Japan Medical Dynamic Marketing (FRA:JMD) EBIT: €3.9 Mil (TTM As of Mar. 2026)


FRA:JMD Japan Medical Dynamic Marketing Inc FRA:JMD
77 GF Score
Price €4.98
GF Value €3.39
! 12 Warning Signs
View Full Analysis

What is Japan Medical Dynamic Marketing EBIT?

Japan Medical Dynamic Marketing FRA:JMD +2.89% 77 EBIT is €3.9 Mil as of Mar. 2026. GuruFocus rates FRA:JMD with a GF Score™ of 77/100 and a GF Value™ of €3.39. The stock has 12 warning signs investors should review.

Japan Medical Dynamic Marketing's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €0.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €3.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Japan Medical Dynamic Marketing's annualized ROC % for the quarter that ended in Mar. 2026 was 0.00%. Japan Medical Dynamic Marketing's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 1.50%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Japan Medical Dynamic Marketing's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.62%.


Japan Medical Dynamic Marketing  (FRA:JMD) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Japan Medical Dynamic Marketing's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=1.224 * ( 1 - 100% )/( (168.981 + 167.998)/ 2 )
=0/168.4895
=0.00 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Japan Medical Dynamic Marketing's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2.288/( ( (43.914 + max(109.208, 0)) + (47.869 + max(103.598, 0)) )/ 2 )
=2.288/( ( 153.122 + 151.467 )/ 2 )
=2.288/152.2945
=1.50 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(29.141 + 88 + 4.054) - (6.255 + 0 + 5.732)
=109.208

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(28.55 + 88.178 + 2.018) - (9.556 + 0 + 5.592)
=103.598

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Japan Medical Dynamic Marketing's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=3.892/148.345
=2.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Japan Medical Dynamic Marketing EBIT Related Terms


Japan Medical Dynamic Marketing EBIT Historical Data

* Premium members only.

The historical data trend for Japan Medical Dynamic Marketing's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Medical Dynamic Marketing EBIT Chart

Japan Medical Dynamic Marketing Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.28 12.49 10.25 -1.66 3.79

Japan Medical Dynamic Marketing Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.15 0.84 0.35 2.13 0.57

FRA:JMD vs ABT, SYK, MDT: EBIT Comparison

For the Medical Devices subindustry, Japan Medical Dynamic Marketing's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Japan Medical Dynamic Marketing EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Japan Medical Dynamic Marketing's EV-to-EBIT falls into.


FRA:JMD
77GF Score
Japan Medical Dynamic Marketing Inc FRA:JMD
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Japan Medical Dynamic Marketing EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €3.9 Mil mean?
Japan Medical Dynamic Marketing (FRA:JMD) has a EBIT of €3.9 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Japan Medical Dynamic Marketing.
Is Japan Medical Dynamic Marketing's EBIT too high?
Japan Medical Dynamic Marketing's current EBIT is €3.9 Mil. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's EBIT compare to ABT and SYK?
Japan Medical Dynamic Marketing's EBIT of €3.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Japan Medical Dynamic Marketing. Japan Medical Dynamic Marketing's current EBIT is €3.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (FRA:JMD) has a current EBIT of €3.9 Mil. The stock's GF Value™ is €3.39, compared to a current price of €4.98 — trading 46.9% above its estimated fair value. The current EBIT is €3.9 Mil. Japan Medical Dynamic Marketing's overall GF Score™ is 77/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (FRA:JMD), the current EBIT is €3.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Medical Dynamic Marketing (FRA:JMD) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued. The current stock price of €4.98 is trading 46.9% above its estimated GF Value™ of €3.39.

Key valuation signals for FRA:JMD:

  • EBIT: €3.9 Mil
  • GF Value™: €3.39 vs. price of €4.98 (46.9% above fair value)
  • GF Score™: 77/100 with 12 warning signs

No single metric tells the full story. See the FRA:JMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Japan Medical Dynamic Marketing Business Description

Other Exchanges JMDMF:USA7600:Japan
Address 12-2, Ichigayadaimachi, Shinjuku-ku, Tokyo, JPN, 162-0066
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
77GF Score

Get the complete analysis for FRA:JMD

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.98
Price
€3.39
GF Value